ARCHIVES

House Measure Would Eliminate AHRQ, Rescind PCORI, Cut Outcomes Research, And Halt NIH’s Title 42 Hiring Program

This article is from The Cancer Letter archive.

Vol. 38 No. 29 | July 20, 2012

Download PDF Visit The Full Archive

Related Articles

Cancer Telethon Attracts Small Audience, Generates Expectations-And Questions.

September 12, 2008

Early HER2 Positive Patients At Higher Risk of Recurrence

January 30, 2009

Schmitt To Chair Senate Health Appropriations Subcommittee

January 2, 1981

Drugs and Targets: Akynzeo approved for chemotherapy-related nausea

October 10, 2014

FDA Approves Lilly’s Alimta For Metastatic NSCLC

August 27, 2004

Alvarez Named New President of The Society of Gynecologic Oncology; Society Restructures

April 13, 2012